Delivery Order SPE2DB20D3103-SPE2DB22FP9K9

Award Date 9/20/22
Potential Completion Date 9/21/22
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,511.52 Firm Fixed Price contract is a Delivery Order that provides 4,561,170,454 units of hydroxychloroquine 200 mg tablets to support military and federal healthcare programs. The contract has a period of performance through June 8, 2023 and was awarded on June 7, 2023. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,632.85 delivery order contract is for the supply of hydroxychloroquine 200 mg tablets. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of hydroxychloroquine 200 mg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a ceiling value of $1,785.97. The contract is a delivery order with a firm-fixed price pricing type and an ultimate completion date of August 20, 2024. This award is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hydroxychloroquine 200 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,408.15. The award date was March 28, 2022, with an ultimate completion date of March 29, 2022. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,749.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxychloroquine 200 mg tablets in 100-count packages. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is for the supply of 4,565,362,866 units of hydroxychloroquine 200 mg tablets, packaged in 500-count bottles. The contract is a firm-fixed-price Delivery Order with a ceiling value of $3,368.33 and an ultimate completion date of August 7, 2024. This award is not associated with any set-aside program....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,932,255 tablets of Hydroxychloroquine 200 mg, a critical pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $8,276.28 and a completion date of July 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of hydroxychloroquine 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a delivery order with a ceiling value of $2,447.91 and a firm fixed price pricing type. The contract has no set-aside designation, indicating it was awarded through full and open competition. The contract is...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,182.82 fixed-price contract is for the delivery of Plaquenil (hydroxychloroquine) 200 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP9K9
    Delivery Order

This federal contract award, with identification number SPE2DB20D3103|SPE2DB22FP9K9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.32 firm fixed-price delivery order is for the supply of 4,558,528,321 units of hydroxychloroquine 200 mg tablets. The contract has a completion date of September 21, 2022 and was awarded on September 20, 2022. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025, has an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical to provide a range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:45 AM